Joanne Turner
Adult Health · Columbia, SCNPI 1225140973
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,338 of the $3,923 with a category attached, or 85.1%. 18 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 40.2% of the total.
Across 179 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$2K
- Axsome Therapeutics, Inc.$677
- Harmony Biosciences LLC$496
- Avadel CNS Pharmaceuticals, LLC$239
- Fisher & Paykel Healthcare Inc$170
- Arbor Pharmaceuticals, Inc.$165
- plus $600 from 12 others
What the payments were for
- Food & beverage$3,33885%
- Education$58515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 59 | $1,577 |
| Axsome Therapeutics, Inc. | 32 | $677 |
| Harmony Biosciences LLC | 24 | $496 |
| Avadel CNS Pharmaceuticals, LLC | 12 | $239 |
| Fisher & Paykel Healthcare Inc | 6 | $170 |
| Arbor Pharmaceuticals, Inc. | 13 | $165 |
| Azurity Pharmaceuticals, Inc. | 10 | $147 |
| Inspire Medical Systems, Inc. | 5 | $95 |
| Abbott | 4 | $77 |
| Eisai Inc. | 3 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $55 |
| Sanofi | 1 | $36 |
| Merck | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Resmed Corp | 1 | $16 |
| Corium, LLC | 1 | $15 |
How this compares
$3,923 in reported general payments places this provider in the 80th percentile of 292 adult health providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 33 | $623,662 |
| Sodium Oxybate | 13 | $158,776 |
| HorizantGabapentin Enacarbil | 13 | $28,896 |
| Modafinil | 169 | $19,689 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 289 | $8,562 |
| BelsomraSuvorexant | 20 | $8,475 |
| Eszopiclone | 206 | $3,681 |
| Armodafinil | 70 | $2,877 |
| Zolpidem Tartrate | 305 | $1,914 |
| Gabapentin | 140 | $1,683 |
| Clonazepam | 188 | $1,325 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 66 | $1,320 |
| Ropinirole Hcl | 58 | $1,216 |
| Trazodone Hcl | 107 | $929 |
| Zaleplon | 46 | $780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Arbor Pharmaceuticals, Inc.Horizant | $165 | $28,89613 claims |
| MerckBelsomra | $32 | $8,47520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 292 adult health providers in South Carolina.
Other adult health in Columbia
- Kelsey DardenColumbia$7K
- Towanna EnochColumbia$5K
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
- Melissa McCarterSpartanburg$12K
- Andrea OlsonWest Columbia$12K
- Jennifer BrittIrmo$11K
- Nichole SnowSpartanburg$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.